The US Food and Drug Administration approvedAbbott’s Aveir dual chamber (DR) leadless pacemaker system.
About 80% of people who need a pacemaker to treat bradycardia or another abnormal heart rhythm will need dual-chamber...
The FDA approved Abbott’s Aveir DR dual-chamber leadless pacemaker system, which will complement Abbott’s Aveir VR technology and help Abbott compete directly with Medtronic in the growing leadless cardiac rhythm management device market.
The US Food and Drug Administration approvedAbbott’s Aveir dual chamber (DR) leadless pacemaker system.
About 80% of people who need a pacemaker to treat bradycardia or another abnormal heart rhythm will need dual-chamber...
Stay current on regulatory guidelines from around the world with Medtech Insight's Guidance Tracker. Over 50 documents have been posted on the tracker since its last update.
Finland has initiated a project to improve the effectiveness of the monitoring of software intended for medical use and to ensure that software placed on its market meets the requirements set for it.
Broad participation by EU member states in a new pilot to test a unified procedure for evaluating applications for combined drug and IVD studies shows they recognize its value, says Monique Al, vice-chair of the Clinical Trials Coordination Group.